Immunochromatography and laboratory serologies: an evaluation of immunodiagnoses in prenatal care.

Pattrícia Da Rosa Damiani,Marli Terezinha Stein Backes,Patrícia Hermes Stoco,Gustavo Lopes Soares,Vanessa Martinhago Borges Fernandes

doi:10.1590/0034-7167-2020-0877

Pattrícia Da Rosa Damiani, Marli Terezinha Stein Backes + Show 3 more

Open Access

https://doi.org/10.1590/0034-7167-2020-0877

Copy DOI

Abstract

to describe the use of affinity chromatographies and laboratory serologies in the evaluation of immunodiagnoses during prenatal. quantitative study, characterized as a descriptive observational research. Data was collected from the records of 46 pregnant women who were in prenatal follow up in the Primary Health Care in a capital in the South of Brazil. The data found was codified and analyzed using descriptive statistics. a mean of 43.1 days was found to take place between the request of laboratory serology and the evaluation by a professional. It was also found that 21.7% of pregnant women did not collect the serologies requested during the first prenatal consultation, and that the affinity chromatographies were only applied in 10.8% of the participants. in spite of the studies for the improvement of prenatal consultations, for the provision of new technologies and for the permanent education offered to the professionals, there are still questions that make the actual implementation of affinity chromatographies more difficult.

Highlights

Public policies for woman and child health care have been built according to social demands and scientific-technological advances
Considering this logic, prenatal care goes through a path of advances in the search for quality and safety for the mother-child dyad, instituting actions related to prevention, diagnostic, and to the clinical management of potential obstetric complications or existing pathologies, guaranteeing an early treatment and a safe birth to the newborn[1,2,3]
The Ministry of Health prescribes that immunodiagnostic tests should take place in the first three trimesters of pregnancy

Summary

Introduction

Public policies for woman and child health care have been built according to social demands and scientific-technological advances Considering this logic, prenatal care goes through a path of advances in the search for quality and safety for the mother-child dyad, instituting actions related to prevention, diagnostic, and to the clinical management of potential obstetric complications or existing pathologies, guaranteeing an early treatment and a safe birth to the newborn[1,2,3]. With this in mind, the Ministry of Health prescribes that immunodiagnostic tests (laboratory serologies or immunochromatographies) should take place in the first three trimesters of pregnancy. Serological laboratory exams, in turn, require specific laboratory equipment, hours or days to show their results, and data collection through venipuncture in environments other than the health centers[6]

Objectives

Results

Discussion

Conclusion